Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective

Jie Dai, Ping Yang, Angela Cox, Gening Jiang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary diseases that commonly coexist and present a number of clinical challenges. COPD confers a higher risk for lung cancer development, but available chemopreventive measures remain rudimentary. Current studies have shown a marked benefit of cancer screening in the COPD population, although challenges remain, including the common underdiagnosis of COPD. COPD-associated lung cancer presents distinct clinical features. Treatment for lung cancer coexisting with COPD is challenging as COPD may increase postoperative morbidities and decrease survival. In this review, we outline current progress in the understanding of the clinical association between COPD and lung cancer, and suggest possible cancer prevention strategies in this patient population.

Original languageEnglish (US)
Pages (from-to)18513-18524
Number of pages12
JournalOncotarget
Volume8
Issue number11
DOIs
StatePublished - 2017

Fingerprint

Chronic Obstructive Pulmonary Disease
Lung Neoplasms
Early Detection of Cancer
Population
Lung Diseases
Morbidity
Survival
Neoplasms

Keywords

  • Association
  • Chronic obstructive pulmonary disease
  • Lung cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Lung cancer and chronic obstructive pulmonary disease : From a clinical perspective. / Dai, Jie; Yang, Ping; Cox, Angela; Jiang, Gening.

In: Oncotarget, Vol. 8, No. 11, 2017, p. 18513-18524.

Research output: Contribution to journalArticle

Dai, Jie ; Yang, Ping ; Cox, Angela ; Jiang, Gening. / Lung cancer and chronic obstructive pulmonary disease : From a clinical perspective. In: Oncotarget. 2017 ; Vol. 8, No. 11. pp. 18513-18524.
@article{0b3cbab1919449269ffa914833dffaec,
title = "Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective",
abstract = "Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary diseases that commonly coexist and present a number of clinical challenges. COPD confers a higher risk for lung cancer development, but available chemopreventive measures remain rudimentary. Current studies have shown a marked benefit of cancer screening in the COPD population, although challenges remain, including the common underdiagnosis of COPD. COPD-associated lung cancer presents distinct clinical features. Treatment for lung cancer coexisting with COPD is challenging as COPD may increase postoperative morbidities and decrease survival. In this review, we outline current progress in the understanding of the clinical association between COPD and lung cancer, and suggest possible cancer prevention strategies in this patient population.",
keywords = "Association, Chronic obstructive pulmonary disease, Lung cancer",
author = "Jie Dai and Ping Yang and Angela Cox and Gening Jiang",
year = "2017",
doi = "10.18632/oncotarget.14505",
language = "English (US)",
volume = "8",
pages = "18513--18524",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "11",

}

TY - JOUR

T1 - Lung cancer and chronic obstructive pulmonary disease

T2 - From a clinical perspective

AU - Dai, Jie

AU - Yang, Ping

AU - Cox, Angela

AU - Jiang, Gening

PY - 2017

Y1 - 2017

N2 - Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary diseases that commonly coexist and present a number of clinical challenges. COPD confers a higher risk for lung cancer development, but available chemopreventive measures remain rudimentary. Current studies have shown a marked benefit of cancer screening in the COPD population, although challenges remain, including the common underdiagnosis of COPD. COPD-associated lung cancer presents distinct clinical features. Treatment for lung cancer coexisting with COPD is challenging as COPD may increase postoperative morbidities and decrease survival. In this review, we outline current progress in the understanding of the clinical association between COPD and lung cancer, and suggest possible cancer prevention strategies in this patient population.

AB - Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary diseases that commonly coexist and present a number of clinical challenges. COPD confers a higher risk for lung cancer development, but available chemopreventive measures remain rudimentary. Current studies have shown a marked benefit of cancer screening in the COPD population, although challenges remain, including the common underdiagnosis of COPD. COPD-associated lung cancer presents distinct clinical features. Treatment for lung cancer coexisting with COPD is challenging as COPD may increase postoperative morbidities and decrease survival. In this review, we outline current progress in the understanding of the clinical association between COPD and lung cancer, and suggest possible cancer prevention strategies in this patient population.

KW - Association

KW - Chronic obstructive pulmonary disease

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85015229258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015229258&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.14505

DO - 10.18632/oncotarget.14505

M3 - Article

AN - SCOPUS:85015229258

VL - 8

SP - 18513

EP - 18524

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 11

ER -